🇺🇸 Stem Cell in United States
216 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 216
Most-reported reactions
- Mucosal Inflammation — 35 reports (16.2%)
- Drug Toxicity — 28 reports (12.96%)
- Stem Cell Transplant — 25 reports (11.57%)
- Neutropenia — 21 reports (9.72%)
- Sepsis — 20 reports (9.26%)
- Diarrhoea — 18 reports (8.33%)
- Nausea — 18 reports (8.33%)
- Vomiting — 18 reports (8.33%)
- Febrile Neutropenia — 17 reports (7.87%)
- Pyrexia — 16 reports (7.41%)
Other Neurology approved in United States
Frequently asked questions
Is Stem Cell approved in United States?
Stem Cell does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Stem Cell in United States?
Neurogen Brain and Spine Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.